NCT03526250 2024-11-01Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)National Cancer Institute (NCI)Phase 2 Completed23 enrolled 11 charts
NCT02897375 2023-10-10Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsEmory UniversityPhase 1 Completed71 enrolled
NCT01209598 2017-11-06PD0332991 (Palbociclib) in Patients With Advanced or Metastatic LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed90 enrolled 7 charts